Mylan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS, and what generic and branded alternatives to MYLAN LABS drugs are available?
MYLAN LABS has one hundred and sixteen approved drugs.
There are eleven tentative approvals on MYLAN LABS drugs.
Drugs and US Patents for Mylan Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 203628-001 | Mar 10, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Labs Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 200145-001 | Jul 25, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Labs Ltd | STAVUDINE | stavudine | CAPSULE;ORAL | 078775-001 | Jan 5, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.